VERA Kelas A Vera Therapeutics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 10, 2026
$30,42
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$23,05rendah 52m
$56,05tinggi 52m
P/E
-10.9
EPS
$-4.66
lencana Anda
Rentang 52M
$23–$56
Peringkat Analis
BUY
Target Harga
$78
P/E
-10.9
ROE
-55.9%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
VERA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$30.42
P/E
-10.9
EPS
$-4.66
ROE
-55.9%
Rentang 52M
$23–$56
VERA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-4.662021-12-31 → 2025-12-31
Arus Kas Bebas$-242M2022-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | VERA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -10.9rata-rata 5T ≈-10.0 | ≈-10.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | VERA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -43.1%rata-rata 5T ≈-54.4% | ≈-54.4% | -40.3% | Lemah | |
| ROE | -55.9%rata-rata 5T ≈-63.2% | ≈-63.2% | -54.5% | Lemah | |
| ROIC | -52.2%rata-rata 5T ≈-69.8% | ≈-69.8% | -52.2% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | VERA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 10.9rata-rata 5T ≈12.5 | ≈12.5 | 13.0 | Di bawah rata-rata | |
| Quick Ratio (Rasio Cepat) | 13.4rata-rata 5T ≈12.1 | ≈12.1 | 6.6 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-14.3%
Laporan Berikutnya
Nov 03, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 3, 2026 | $-1.52 | $-1.61 | 5.5% |
| 31 Maret 2026 | $-1.69 | $-1.35 | -24.9% | |
| 31 Des. 2025 | $-1.39 | $-1.31 | -6.3% | |
| 30 Sep. 2025 | $-1.26 | $-1.16 | -8.8% | |
| 30 Juni 2025 | $-1.20 | $-0.84 | -43.2% | |
| 31 Maret 2025 | $-0.81 | $-0.75 | -8.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $215M | $126M | $78M | $69M | $22M | $45M | |
| SG&A Expense | $100M | $41M | $24M | $22M | $12M | $4M | |
| Operating Expenses | $315M | $167M | $102M | $91M | $34M | $52M | |
| Operating Income | $-315M | $-167M | $-102M | $-91M | $-34M | $-52M | |
| Interest Expense | · | · | $4M | $992.0K | $20.0K | $166.0K | |
| Interest Income | $24M | $21M | $8M | $2M | $15.0K | $8.0K | |
| Other Non-op | $16M | $15M | $6M | $2M | $2M | $-1M | |
| Pretax Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $-1.0K | |
| Net Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| EPS (Basic) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| EPS (Diluted) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| Shares (Basic) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| Shares (Diluted) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| EBITDA | $-315M | $-167M | $-106M | $-92M | $-34M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $355M | $93M | $46M | $43M | $80M | $54M | |
| Short-term Investments | $360M | $548M | $115M | $71M | $0 | · | |
| Prepaid Expense | $14M | $10M | $11M | $11M | $3M | $557.0K | |
| Other Current Assets | $3M | $1M | $2M | $719.0K | $480.0K | $392.0K | |
| Current Assets | $729M | $651M | $172M | $126M | $83M | $54M | |
| PP&E (Net) | $1M | $960.0K | $92.0K | $51.0K | $0 | · | |
| Other Non-current Assets | $6M | · | · | · | · | · | |
| Total Assets | $735M | $656M | $176M | $131M | $84M | $55M | |
| Accounts Payable | $22M | $8M | $11M | $12M | $1M | $909.0K | |
| Accrued Liabilities | $32M | $16M | $9M | $11M | $6M | $535.0K | |
| Current Liabilities | $53M | $25M | $22M | $26M | $8M | $2M | |
| Capital Leases | $2M | $2M | $1M | $4M | $0 | · | |
| Other Non-current Liabilities | $2M | · | · | · | · | · | |
| Total Liabilities | $130M | $79M | $74M | $55M | $14M | $4M | |
| Long-term Debt | $75M | $51M | $50M | $25M | $5M | $0 | |
| Common Stock | $71.0K | $64.0K | $44.0K | $28.0K | · | · | |
| Retained Earnings | $-761M | $-461M | $-309M | $-213M | $-124M | $-91M | |
| AOCI | $786.0K | $393.0K | $251.0K | $-224.0K | $0 | · | |
| Stockholders' Equity | $605M | $577M | $102M | $77M | $70M | $-89M | |
| Liabilities + Equity | $735M | $656M | $176M | $131M | $84M | $55M |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $468.0K | $105.0K | $21.0K | $-846.0K | $176.0K | $251.0K | |
| Stock-based Comp | $38M | $21M | $11M | $9M | $3M | $331.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | $0 | $3M | |
| Other Non-cash | $20M | $-3M | $-4M | $13M | $6M | · | |
| Operating Cash Flow | $-241M | $-135M | $-92M | $-68M | $-24M | $-35M | |
| CapEx | $630.0K | $972.0K | $63.0K | $62.0K | $0 | $99.0K | |
| Investing Cash Flow | $194M | $-425M | $-39M | $-71M | $-4M | $-42.0K | |
| Stock Issued | · | · | · | $2M | $0 | · | |
| Stock Repurchased | $0 | $13.0K | $0 | · | · | · | |
| Net Stock Activity | $0 | $-13.0K | · | $2M | $51M | · | |
| Financing Cash Flow | $309M | $607M | $134M | $102M | $54M | $85M | |
| Net Change in Cash | $262M | $47M | $2M | $-36M | $26M | $50M | |
| Taxes Paid | $17.0K | $1.0K | $1.0K | · | · | · | |
| Free Cash Flow | $-242M | $-136M | $-92M | $-68M | · | · | |
| Levered FCF | · | · | $-96M | $-69M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -43.1% | -36.6% | -62.5% | -82.8% | -47.2% | · | |
| ROE | -55.9% | -35.1% | -85.2% | -97.5% | -42.1% | · | |
| ROIC | -52.2% | -29.0% | -100.3% | -118.2% | -49.4% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 | · | |
| Quick Ratio | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 | · | |
| Interest Coverage | · | · | -26.9 | -91.6 | -1720.1 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $-3.75 | $-2.43 | $-2.16 | $-2.54 | · | · | |
| EPS (TTM) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-300M | $-152M | $-96M | $-89M | $-33M | · | |
| P/E | -10.9 | -15.4 | -6.8 | -5.8 | -11.0 | · | |
| Earnings Yield | -9.2% | -6.5% | -14.6% | -17.3% | -9.1% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $60M | $86M | $59M | $56M | $58M | $41M | $33M | $40M | $29M | $23M | $16M | $16M | $25M | $27M | $20M | $10M | |
| SG&A Expense | $52M | $39M | $35M | $27M | $22M | $16M | $16M | $9M | $8M | $8M | $6M | $6M | $6M | $7M | $6M | $5M | |
| Operating Expenses | $112M | $125M | $94M | $84M | $80M | $57M | $49M | $50M | $37M | $31M | $22M | $22M | $31M | $34M | $25M | $15M | |
| Operating Income | $-112M | $-125M | $-94M | $-84M | $-80M | $-57M | $-49M | $-50M | $-37M | $-31M | $-22M | $-22M | $-31M | $-34M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | $2M | $2M | $943.0K | $914.0K | $874.0K | $599.0K | $147.0K | $128.0K | |
| Interest Income | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $5M | $4M | $2M | $2M | $2M | $894.0K | $567.0K | $263.0K | |
| Other Non-op | $3M | $4M | $3M | $4M | $4M | $6M | $5M | $3M | $4M | $3M | $2M | $2M | $1M | $1M | $565.0K | $204.0K | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $0 | $0 | |
| Net Income | $-109M | $-121M | $-91M | $-80M | $-77M | $-52M | $-43M | $-47M | $-34M | $-28M | $-20M | $-20M | $-30M | $-32M | $-25M | $-15M | |
| EPS (Basic) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| EPS (Diluted) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| Shares (Basic) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| Shares (Diluted) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| EBITDA | $-112M | $-125M | · | $-84M | $-80M | $-57M | · | $-50M | $-37M | $-33M | $-22M | $-22M | $-32M | · | $-25M | $-15M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $114M | $355M | $58M | $49M | $55M | $93M | $27M | $25M | $69M | $27M | $34M | $137M | $43M | $30M | $50M | |
| Short-term Investments | $450M | $482M | $360M | $440M | $508M | $535M | $548M | $326M | $359M | $335M | $132M | $147M | $60M | $71M | $84M | $82M | |
| Prepaid Expense | $28M | $19M | $14M | $14M | $15M | $16M | $10M | $11M | $10M | $13M | $12M | $10M | $7M | $11M | $11M | $10M | |
| Other Current Assets | $4M | $2M | $3M | $1M | $2M | $2M | $1M | $1M | $429.0K | $568.0K | $2M | $1M | $883.0K | $719.0K | $792.0K | $776.0K | |
| Current Assets | $527M | $616M | $729M | $511M | $571M | $606M | $651M | $364M | $395M | $416M | $172M | $191M | $204M | $126M | $125M | $142M | |
| PP&E (Net) | $813.0K | $945.0K | $1M | $1M | $1M | $1M | $960.0K | $368.0K | $155.0K | $81.0K | $34.0K | $40.0K | $45.0K | $51.0K | $56.0K | $21.0K | |
| Other Non-current Assets | $5M | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M | |
| Accounts Payable | $15M | $14M | $22M | $18M | $13M | $9M | $8M | $5M | $5M | $5M | $12M | $13M | $5M | $12M | $7M | $7M | |
| Accrued Liabilities | $34M | $31M | $31M | $23M | $20M | $11M | $16M | $20M | $12M | $7M | $10M | $11M | $16M | $11M | $6M | $8M | |
| Current Liabilities | $48M | $45M | $53M | $42M | $34M | $22M | $25M | $26M | $18M | $15M | $25M | $27M | $24M | $26M | $16M | $17M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | $2M | $3M | $455.0K | $919.0K | $2M | $3M | $3M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $125M | $122M | $130M | $119M | $110M | $75M | $79M | $80M | $69M | $66M | $52M | $55M | $52M | $55M | $26M | $27M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $74M | $51M | $51M | $50M | $50M | $50M | $25M | $25M | $25M | $25M | $5M | $5M | |
| Common Stock | $72.0K | $72.0K | $71.0K | $64.0K | $64.0K | $64.0K | $64.0K | $55.0K | $55.0K | $54.0K | · | · | · | $28.0K | · | · | |
| Retained Earnings | $-991M | $-882M | $-761M | $-670M | $-589M | $-513M | $-461M | $-418M | $-371M | $-337M | $-283M | $-263M | $-243M | $-213M | $-181M | $-156M | |
| AOCI | $-403.0K | $-156.0K | $786.0K | $881.0K | $527.0K | $654.0K | $393.0K | $1M | $-450.0K | $-173.0K | $-75.0K | $-142.0K | $-4.0K | $-224.0K | $-279.0K | $-152.0K | |
| Stockholders' Equity | $408M | $500M | $605M | $399M | $468M | $535M | $577M | $289M | $328M | $354M | $124M | $141M | $158M | $77M | $106M | $122M | |
| Liabilities + Equity | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $132.0K | $140.0K | $135.0K | $129.0K | $119.0K | $85.0K | $55.0K | $24.0K | $1M | $11.0K | $1M | $517.0K | $-506.0K | $-597.0K | $-152.0K | $-106.0K | |
| Stock-based Comp | $16M | $13M | $11M | $10M | $9M | $8M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-cash | · | $1M | · | · | · | $-11M | · | · | · | $-8M | · | · | $2M | · | · | · | |
| Operating Cash Flow | $-100M | $-106M | $-70M | $-62M | $-55M | $-54M | $-39M | $-37M | $-25M | $-34M | $-23M | $-18M | $-26M | $-21M | $-18M | $-19M | |
| CapEx | $0 | $23.0K | $102.0K | $133.0K | $208.0K | $187.0K | $645.0K | $238.0K | $89.0K | $0 | $0 | $0 | $0 | $0 | $38.0K | $6.0K | |
| Investing Cash Flow | $33M | $-138M | $81M | $70M | $29M | $15M | $-221M | $38M | $-23M | $-219M | $16M | $-86M | $12M | $13M | $-2M | $-42M | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $4M | $286M | $797.0K | $20M | $2M | $326M | $739.0K | $3M | $277M | $297.0K | $432.0K | $108M | $21M | $908.0K | $48.0K | |
| Net Change in Cash | $-65M | $-240M | $297M | $9M | $-6M | $-38M | $65M | $2M | $-44M | $23M | $-6M | $-104M | $94M | $13M | $-20M | $-61M | |
| Free Cash Flow | · | $-107M | · | · | · | $-55M | · | · | · | · | · | · | $-26M | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | -19.7% | · | -18.1% | -15.7% | -10.0% | · | -17.1% | -11.4% | -9.0% | -13.1% | -11.7% | -16.1% | · | -22.2% | -12.0% | |
| ROE | -25.0% | -23.4% | · | -23.3% | -19.2% | -11.6% | · | -22.6% | -14.4% | -11.1% | -17.5% | -15.4% | -20.6% | · | -25.8% | -13.9% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.6 | · | 12.2 | 17.0 | 27.7 | · | 13.8 | 21.4 | 28.6 | 7.0 | 7.1 | 8.7 | · | 7.9 | 8.2 | |
| Quick Ratio | 10.3 | 13.2 | · | 11.9 | 16.6 | 26.9 | · | 13.4 | 20.9 | 27.8 | 6.5 | 6.7 | 8.4 | · | 7.2 | 7.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -19.5 | -16.3 | -23.1 | -24.0 | -35.8 | · | -171.7 | -117.6 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-1.49 | · | · | · | $-0.85 | · | · | · | $-0.66 | · | · | $-0.70 | · | · | · | |
| EPS (TTM) | $-5.86 | $-5.54 | · | $-3.99 | $-3.58 | $-3.00 | · | $-2.57 | $-2.17 | $-2.01 | $-2.89 | $-3.35 | $-3.44 | · | $-3.14 | $-2.59 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-402M | $-369M | · | $-252M | $-218M | $-175M | · | $-134M | $-108M | $-94M | $-103M | $-107M | $-102M | · | $-73M | $-56M | |
| P/E | -7.3 | -7.3 | · | -7.3 | -6.6 | -8.0 | · | -17.2 | -16.7 | -21.5 | -4.7 | -4.8 | -2.3 | · | -6.8 | -5.3 | |
| Earnings Yield | -13.7% | -13.8% | · | -13.7% | -15.2% | -12.5% | · | -5.8% | -6.0% | -4.7% | -21.1% | -20.9% | -44.3% | · | -14.7% | -19.0% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-300M | $-152M | $-96M | $-89M | $-33M |
| EPS Dilusian | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 |
| Rasio Cepat | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-242M | $-136M | $-92M | $-68M | · |
Pemilik institusional (13F) 240 pengaju · $3.4B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
240
Nilai yang dipegang
$3.4B
Posisi baru
34
Posisi yang keluar
35
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 34 (-19 vs Kuartal sebelumnya) | 35 (+5 vs Kuartal sebelumnya) | 99 (+4 vs Kuartal sebelumnya) | 65 (+2 vs Kuartal sebelumnya) | +4.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BlackRock, Inc. | $246.636.382 | 5.747.760 | 7,34% | Saham |
| Avoro Capital Advisors LLC | $245.612.034 | 5.723.888 | 7,31% | Saham |
| VANGUARD GROUP INC | $180.805.107 | 3.570.401 | 5,38% | Saham |
| STATE STREET CORP | $178.024.407 | 4.148.786 | 5,30% | Saham |
| Deep Track Capital, LP | $171.640.000 | 4.000.000 | 5,11% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $168.052.724 | 3.916.400 | 5,00% | Saham |
| Kynam Capital Management, LP | $124.012.432 | 2.890.059 | 3,69% | Saham |
| MORGAN STANLEY | $120.124.806 | 2.799.459 | 3,57% | Saham |
| Sofinnova Investments, Inc. | $119.889.982 | 2.793.987 | 3,57% | Saham |
| FMR LLC | $119.035.323 | 2.774.070 | 3,54% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $118.234.772 | 2.755.413 | 3,52% | Saham |
| Eversept Partners, LP | $94.949.961 | 2.212.770 | 2,82% | Saham |
| Logos Global Management LP | $94.402.000 | 2.200.000 | 2,81% | Saham |
| Integral Health Asset Management, LLC | $75.092.500 | 1.750.000 | 2,23% | Saham |
| Bellevue Group AG | $73.410.771 | 1.710.808 | 2,18% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $72.637.914 | 1.692.442 | 2,16% | Saham |
| ALLIANCEBERNSTEIN L.P. | $64.007.660 | 1.591.043 | 1,90% | Saham |
| GOLDMAN SACHS GROUP INC | $59.251.630 | 1.380.835 | 1,76% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $55.585.829 | 1.295.405 | 1,65% | Saham |
| Pictet Asset Management Holding SA | $53.625.486 | 1.249.414 | 1,60% | Saham |
| DEUTSCHE BANK AG\ | $47.291.369 | 1.102.106 | 1,41% | Saham |
| Qube Research & Technologies Ltd | $46.479.211 | 1.083.179 | 1,38% | Saham |
| Woodline Partners LP | $42.954.498 | 1.001.037 | 1,28% | Saham |
| AMERICAN CENTURY COMPANIES INC | $37.170.604 | 866.243 | 1,11% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $27.585.680 | 642.873 | 0,82% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $27.572.336 | 642.562 | 0,82% | Saham |
| GREAT POINT PARTNERS LLC | $25.781.873 | 600.836 | 0,77% | Saham |
| BANK OF AMERICA CORP /DE/ | $25.321.319 | 590.103 | 0,75% | Saham |
| NORTHERN TRUST CORP | $24.936.117 | 581.126 | 0,74% | Saham |
| BRAIDWELL LP | $24.232.307 | 564.724 | 0,72% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $23.386.508 | 545.013 | 0,70% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $22.650.172 | 527.853 | 0,67% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22.040.459 | 510.787 | 0,66% | Saham |
| Davern Capital Partners, LP | $21.404.881 | 498.832 | 0,64% | Saham |
| Candriam S.C.A. | $20.066.803 | 468.099 | 0,60% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $19.987.778 | 465.807 | 0,59% | Saham |
| Elmind Capital, LP | $18.730.987 | 436.518 | 0,56% | Saham |
| Rock Springs Capital Management LP | $18.347.629 | 427.584 | 0,55% | Saham |
| Balyasny Asset Management L.P. | $16.089.147 | 374.951 | 0,48% | Saham |
| ORBIMED ADVISORS LLC | $15.859.364 | 369.596 | 0,47% | Saham |
| Ikarian Capital, LLC | $13.302.100 | 310.000 | 0,40% | Saham |
| ARMISTICE CAPITAL, LLC | $12.873.000 | 300.000 | 0,38% | Saham |
| Nuveen, LLC | $12.804.773 | 298.410 | 0,38% | Saham |
| READYSTATE ASSET MANAGEMENT LP | $12.663.342 | 295.114 | 0,38% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $11.994.546 | 279.528 | 0,36% | Saham |
| MILLENNIUM MANAGEMENT LLC | $11.957.215 | 278.658 | 0,36% | Saham |
| CITIGROUP INC | $11.446.585 | 266.758 | 0,34% | Saham |
| UBS Group AG | $10.906.950 | 254.182 | 0,32% | Saham |
| Affinity Asset Advisors, LLC | $10.727.500 | 250.000 | 0,32% | Saham |
| Alphabet Inc. | $10.352.638 | 241.264 | 0,31% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5 Maret 2026 | 4,00% | Amandemen | Investasi pasif | SEC |
| Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×5 pengajuan | 4 Nov. 2024 | · | Pengajuan awal | · | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×5 pengajuan | 26 Maret 2024 | · | Pengajuan awal | Investasi pasif | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP ×2 pengajuan | 7 April 2022 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 12 pejabat · 10 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Marshall Fordyce | PRESIDENT AND CEO | 15 Sep. 2026 M | 235.244 | 0 | 22 | $-9.730.927 |
| Sean Grant | CHIEF FINANCIAL OFFICER | 23 Feb. 2026 S | 114.181 | 0 | 1 | $-207.759 |
| David Lee Johnson | Chief Operating Officer | 23 Feb. 2026 S | 45.727 | 0 | 1 | $-108.266 |
| Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | 11 Sep. 2026 M | 80.754 | 0 | 2 | $-566.752 |
| Nancy Lee Boman | Chief Regulatory Officer | 3 Agu 2026 A | 44.987 | 0 | 0 | $0 |
| Jane Wright Mitchell | Chief Legal Officer | 23 Maret 2026 A | 42.403 | 0 | 0 | $0 |
| Laurence Matthew Skelton | Chief Commercial Officer | 23 Feb. 2026 S | 64.218 | 0 | 1 | $-66.412 |
| Robert Brenner | Chief Medical Officer | 23 Feb. 2026 S | 50.947 | 0 | 1 | $-90.299 |
| William D. Turner | Chief Regulatory Officer | 23 Feb. 2026 S | 45.313 | 0 | 4 | $-1.445.710 |
| Jason S Carter | Chief Legal Officer | 21 Nov. 2025 S | 49.136 | 0 | 1 | $-107.496 |
| Celia Lin | Chief Medical Officer | 21 Agu 2023 S | 11.010 | 0 | 0 | $0 |
| Joanne Curley | Chief Development Officer | 21 Agu 2023 S | 26.962 | 0 | 0 | $0 |
| Kimball Hall | Direktur | 21 Mei 2026 A | · | 0 | 0 | $0 |
| Christy J. Oliger | Direktur | 21 Mei 2026 A | · | 0 | 0 | $0 |
| Andrew Cheng | Direktur | 21 Mei 2026 A | 17.488 | 0 | 0 | $0 |
| Scott W Morrison | Direktur | 21 Mei 2026 A | · | 0 | 0 | $0 |
| Michael Morrissey | Direktur | 21 Mei 2026 A | · | 0 | 0 | $0 |
| Beth C Seidenberg | Direktur | 21 Mei 2026 A | 131.553 | 0 | 0 | $0 |
| Christopher Hite | Direktur | 5 Maret 2026 A | · | 0 | 0 | $0 |
| Dr. Maha Katabi | Direktur | 14 Mei 2025 A | 2.793.987 | 0 | 0 | $0 |
| Kurt Von Emster | Direktur | 18 Mei 2021 C | 2.960.231 | 0 | 0 | $0 |
| COMMODORE CAPITAL LP | Pemilik 10% | 10 Jan. 2024 S | 4.400.000 | 0 | 0 | $0 |
| Abingworth LLP | Pemilik 10% | 13 Mei 2021 A | 2.960.231 | 0 | 0 | $0 |
| James R Meyers | · | 21 Mei 2026 A | · | 0 | 0 | $0 |
| Patrick G. Enright | · | 21 Mei 2026 A | 5.882 | 1 | 0 | $249.985 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 32 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,63% | 9.072 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,58% | 89.811 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,16% | 1.227 NS | 31 Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 68.530 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,15% | 5.108 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,15% | 447.454 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,14% | 601.982 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 367.755 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,07% | 1.634.337 SH | 11 Sep. 2026 | Harian |
| BKSE · BNY Mellon ETF Trust | 0,07% | 1.841 NS | 31 Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 14.351 NS | 31 Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,07% | 30.600 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 16.721 SH | 11 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,05% | 45.356 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 25.265 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,03% | 145.920 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 759.354 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,03% | 128.886 SH | 19 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 20.305 SH | 2 Okt. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20.341 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.757 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,01% | 5.214 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 5.306 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 92.764 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 10.449 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 39.169 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 15.089 SH | 10 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 7.498 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.934.442 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.315 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 2.430 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 63.574 SH | 11 Sep. 2026 | Harian |
VERA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 20 analis
BELI
Target median
$81.50
+167,9%
7 35,0%
Beli Kuat
11 55,0%
Beli
2 10,0%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
14 analis · 2026-10-01Target rata-rata $77.50 +154,8%
← Di bawah semua target
Harga saat ini $30.42
Rendah$34.00
Rata-rata$77.50
Tinggi$100.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| VERA | · | -10.9 | · | · | -55.9% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 10, 2026